| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nancy F Crum-Cianflone | Q58066164 |
| P2093 | author name string | Jhamillia Weekes | |
| Mary Bavaro | |||
| P2860 | cites work | Venous thrombosis among patients with AIDS | Q28167369 |
| Thrombosis and a hypercoagulable state in HIV-infected patients | Q28199193 | ||
| Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases | Q28378450 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Case Report: Venous Thromboembolism in AIDS | Q30437586 | ||
| Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras | Q30482995 | ||
| HIV and thrombosis: a review | Q31934799 | ||
| Anticardiolipin antibodies in acquired immunodeficiency syndrome | Q33416566 | ||
| Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells | Q33495500 | ||
| Risk of symptomatic central venous thrombotic complications in AIDS patients receiving home parenteral nutrition | Q33497257 | ||
| Cerebral venous thrombosis and dual primary infection with human immunodeficiency virus and cytomegalovirus | Q33628072 | ||
| Epidemiology of thrombosis in HIV-infected individuals. The Adult/Adolescent Spectrum of HIV Disease Project | Q33862464 | ||
| A prospective study of the incidence of deep-vein thrombosis within a defined urban population | Q33977258 | ||
| Thromboembolism associated with HIV infection: a case report and review of the literature | Q34020604 | ||
| AIDS and thrombosis: retrospective study of 131 HIV-infected patients | Q34303574 | ||
| HIV/AIDS and the risk of deep vein thrombosis: a study of 45 patients with lower extremity involvement. | Q34307082 | ||
| Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy | Q34332052 | ||
| Is chronic HIV infection associated with venous thrombotic disease? A systematic review | Q36115159 | ||
| Retinal vascular occlusion in patients infected with human immunodeficiency virus | Q36248822 | ||
| Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature | Q36283610 | ||
| Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen | Q36468070 | ||
| Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology review | Q36478255 | ||
| Current update on HIV-associated vascular disease and endothelial dysfunction | Q36764524 | ||
| Human immunodeficiency virus infection and acute deep vein thromboses | Q36951527 | ||
| A rare cause of visual loss in AIDS patients: central retinal vein occlusion | Q37477216 | ||
| Infection of endothelial cells by common human viruses. | Q38663776 | ||
| Mixed arterial and venous thromboembolism in a person with HIV infection | Q38929513 | ||
| Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy | Q39021138 | ||
| Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. | Q40433154 | ||
| Bilateral subclavian vein thrombosis in a patient with acquired immunodeficiency syndrome | Q40522183 | ||
| Intracranial venous sinus thrombosis complicating AIDS-associated nephropathy | Q40559783 | ||
| Superior sagittal sinus thrombosis in a patient with acquired immunodeficiency syndrome. | Q40688714 | ||
| Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study | Q41729173 | ||
| Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. | Q42546609 | ||
| Cytomegalovirus thrombophlebitis after successful DHPG therapy | Q42677885 | ||
| Value of necropsy in acquired immunodeficiency syndrome | Q43609630 | ||
| Deep venous thrombosis and megestrol in patients with HIV infection | Q43892969 | ||
| Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy | Q43934786 | ||
| Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy | Q43974563 | ||
| Increased erythrocyte glutathione peroxidase activity and serum tumor necrosis factor-alpha in HIV-infected patients: relationship to on-going prothrombotic state. | Q43975714 | ||
| Deep venous thrombosis in patients with AIDS. | Q44011007 | ||
| Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors | Q44051880 | ||
| Jugular venous thrombosis in HIV-seropositive man. | Q44091386 | ||
| Thromboembolism in AIDS-related Kaposi's sarcoma | Q44179971 | ||
| Bilateral central retinal vein occlusions in a Chinese patient with HIV-infection | Q44259867 | ||
| Induction of endothelial cell procoagulant activity by cytomegalovirus infection | Q44918591 | ||
| Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series | Q45108757 | ||
| Venous thrombosis in HIV infection | Q45166201 | ||
| Association of venous thromboembolism with human immunodeficiency virus and mortality in veterans | Q45333599 | ||
| Acquired protein S deficiency in children infected with human immunodeficiency virus | Q45767998 | ||
| Protein S deficiency in men with long-term human immunodeficiency virus infection | Q45773588 | ||
| Thromboembolic disease and human immunodeficiency virus infection | Q45777919 | ||
| Fatal disseminated intravascular coagulation and pulmonary thrombosis following blood transfusion in a patient with severe autoimmune hemolytic anemia and human immunodeficiency virus infection | Q45779034 | ||
| Cutaneous thrombosis in human immunodeficiency virus type 1-positive patients and cytomegalovirus viremia | Q45783654 | ||
| Recurrent venous thrombosis in a patient with haemophilia A and HIV infection | Q45882739 | ||
| Progressive prothrombotic state in women with advancing HIV disease | Q46058237 | ||
| Noninfectious branch retinal vein occlusion in HIV-positive patients | Q46258928 | ||
| Recurrent pulmonary thromboembolism in a patient with systemic lupus erythematosus and HIV-1 infection associated with the presence of antibodies to prothrombin: a case report | Q46758150 | ||
| Multiple abdominal venous thrombosis in HIV-seropositive patient | Q47722282 | ||
| Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. | Q47762533 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. | Q53608173 | ||
| Anticardiolipin antibodies associated with HTLV-III infection. | Q55243046 | ||
| Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 | ||
| Thromboembolism associated with acquired immunodeficiency syndrome | Q67574836 | ||
| Protein S deficiency and HIV infection | Q67898417 | ||
| Central retinal vein occlusion in a patient with AIDS. Case report | Q67967590 | ||
| Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients | Q68054564 | ||
| Central Retinal Vein Occlusion in a Middle-Aged Adult with HIV Infection | Q68217724 | ||
| Thromboembolic disease in AIDS is associated with cytomegalovirus disease | Q68279943 | ||
| Cytomegalovirus infection, ascending myelitis, and pulmonary embolus | Q70131847 | ||
| Central retinal vein occlusion in a young patient with seropositive syphilis | Q70255855 | ||
| Lupus anticoagulant in the acquired immunodeficiency syndrome | Q70295138 | ||
| Branch retinal artery occlusion (BRAO) combined with branch retinal vein occlusion (BRVO) and optic disc neovascularization associated with HIV and CMV retinitis | Q71339924 | ||
| Thrombotic tendencies and correlation with clinical status in patients infected with HIV | Q71542518 | ||
| Bilateral central retinal vein occlusions in a patient with acquired immunodeficiency syndrome. Clinicopathologic correlation | Q72028157 | ||
| HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture | Q72188975 | ||
| Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men | Q72497462 | ||
| Cytomegalovirus infection and thrombosis: a causative association? | Q73119592 | ||
| Deep vein thrombosis as a manifestation of the acquired immunodeficiency syndrome? A case report | Q73295425 | ||
| Picture resembling hemicentral retinal vein occlusion in the acquired immunodeficiency syndrome: is it related to cytomegalovirus? | Q73333490 | ||
| Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis | Q73447237 | ||
| HIV infection is a risk factor for venous thromboembolism | Q74260784 | ||
| Pulmonary complications of HIV infection: autopsy findings | Q74576203 | ||
| Superior sagittal sinus thrombosis and HIV | Q74691495 | ||
| Bilateral thrombosis of the internal jugular veins with spasmodic torticollis in a patient with acquired immunodeficiency syndrome and disseminated cytomegalovirus infection | Q77227774 | ||
| Thrombotic events associated with megestrol acetate in patients with AIDS cachexia | Q77727959 | ||
| Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study | Q78133365 | ||
| Acquired protein C and protein S deficiency in HIV-infected patients | Q79341074 | ||
| Venous and arterial thrombosis in patients with HIV infection | Q80109992 | ||
| Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies | Q83347438 | ||
| P433 | issue | 10 | |
| P921 | main subject | patient | Q181600 |
| HIV | Q15787 | ||
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 771-778 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | AIDS Patient Care and STDs | Q15746602 |
| P1476 | title | Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. | |
| P478 | volume | 22 |
| Q51846266 | Acquired Thrombophilia. |
| Q37588991 | Cerebral venous sinus thrombosis in HIV-infected patients: report of 2 cases |
| Q58720888 | Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings |
| Q34342368 | Chronic HIV disease and activation of the coagulation system |
| Q33614424 | Coagulation and morbidity in treated HIV infection |
| Q37639964 | Comparison of the therapeutic dose of warfarin in HIV-infected and HIV-uninfected patients: a study of clinical practice |
| Q36354161 | Depressive symptoms are increased in the early perimenopausal stage in ethnically diverse human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women |
| Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
| Q33401168 | HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV. |
| Q35153652 | HIV-Associated Venous Thromboembolism |
| Q38603109 | Haematological manifestations of human immune deficiency virus infection |
| Q36475983 | High Prevalence of Metabolic Syndrome and Cardiovascular Disease Risk Among People with HIV on Stable ART in Southwestern Uganda |
| Q41836230 | Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study |
| Q91687933 | Incidence of a first venous thrombotic event in people with HIV in the Netherlands: a retrospective cohort study |
| Q35823171 | Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression |
| Q38849283 | Lipid Abnormalities and Inflammation in HIV Inflection |
| Q37946827 | Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? |
| Q27024262 | Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients |
| Q36377944 | Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. |
| Q35238246 | Massive pulmonary thromboembolism and stroke. |
| Q35655728 | Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. |
| Q38095951 | Portal hypertensive biliopathy: A single center experience and literature review |
| Q53835117 | Preliminary Data From the Study of Coagulative Profile of HIV Infected Individuals Suggest a Role For Point Mutations in the Gene in Protein S Deficiency in Individuals Undergoing Highly Antiretroviral Therapy. |
| Q49686914 | Prevalence of lower limb deep venous thrombosis among adult HIV positive patients attending an outpatient clinic at Mulago Hospital |
| Q45863926 | Reply: Interaction between inherited thrombophilia and HIV infection: fact or fancy? |
| Q38038832 | Review: Viral infections and mechanisms of thrombosis and bleeding |
| Q37813128 | Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection |
| Q37007898 | Risk of Venous Thromboembolism in Patients Infected with HIV: A Cohort Study |
| Q35102167 | Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy |
| Q42588928 | Sepsis-associated disseminated intravascular coagulation and thromboembolic disease |
| Q38951776 | The prevalence and radiological findings of pulmonary embolism in HIV-positive patients referred for computed tomography pulmonary angiography in the Western Cape of South Africa |
| Q36098224 | Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study |
| Q90373134 | Utilization of Direct Oral Anticoagulants in People with HIV: Observational Data from the DC Cohort |
| Q39038041 | Venous Thromboembolism Requiring Extended Anticoagulation Among HIV-Infected Patients in a Rural, Resource-Constrained Setting in Western Kenya |
| Q41653892 | Venous thromboembolism among HIV-positive patients and anticoagulation clinic outcomes integrated within the HIV primary care setting |
| Q97640542 | Venous thromboembolism in people living with HIV infection (PWH) |
| Q36291878 | Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals. |
| Q36422981 | Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis. |
| Q35166840 | von Willebrand Factor is elevated in HIV patients with a history of thrombosis. |
Search more.